Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neovasc Inc. NVCN

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.


NDAQ:NVCN - Post by User

<< Previous
Bullboard Posts
Next >>
Post by NOPAINNOGAIN123on Mar 26, 2018 10:19am
161 Views
Post# 27780730

Neovasc Inc (US) (NVCN) Shares Bought by Gagnon Advisors LLC

Neovasc Inc (US) (NVCN) Shares Bought by Gagnon Advisors LLC

Gagnon Advisors LLC increased its stake in shares of Neovasc Inc (US) (NASDAQ:NVCN) (TSE:NVC) by 50.1% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,829,482 shares of the medical equipment provider’s stock after buying an additional 610,376 shares during the quarter. Neovasc Inc (US) comprises 0.8% of Gagnon Advisors LLC’s holdings, making the stock its 28th largest position. Gagnon Advisors LLC owned 2.32% of Neovasc Inc (US) worth $1,098,000 as of its most recent filing with the SEC.

Separately, Hudson Bay Capital Management LP purchased a new stake in Neovasc Inc (US) in the fourth quarter valued at $6,213,000. 41.47% of the stock is currently owned by institutional investors and hedge funds.

<< Previous
Bullboard Posts
Next >>